Agenus | AGEN - Le Chiffre D'Affaires De Vente





Ventes Changement Date
AbbVie USD 15B 1.62B 2026-03
Agenus USD 33.7M 500K 2026-03
Amgen USD 8.62B 1.28B 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Celldex Therapeutics USD 15K 106K 2026-03
CSL USD 8.33B 4.79B 2025-12
Eli Lilly USD 19.8B 500M 2026-03
Gilead Sciences USD 7B 930M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
Glaxosmithkline GBP 10.09B 1.37B 2026-03
Incyte USD 1.27B 240M 2026-03
Intrexon USD 717K 511K 2024-06
J&J USD 24.1B 500M 2026-03
Jiangsu Hengrui CNY 8.14B 300M 2026-03
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
MacroGenics USD 20.8M 20.43M 2026-03
Merck EUR 5.13B 120M 2026-03
Merck USD 16.29B 110M 2026-03
Northwest Biotherapeutics USD 200K 245K 2025-09
Novartis USD 13.11B 226M 2026-03
Novavax USD 147.14M 76.69M 2025-12
Pfizer USD 14.5B 3.08B 2026-03
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Sangamo BioSciences USD 356K 125K 2024-06
Veracyte USD 139.07M 1.53M 2026-03